Discover
EW
Edwards Lifesciences Corporation
81.05
1100 x 80.00
200 x 81.10
bid
ask
-
0.21
0.26%
650 @ 04:00 PM
81.16 +0.11 (0.14%)
Ytd -4.93%
1y 12.49%
79.41
day range
81.71
67.07
52 week range
87.18
Open 81.14 Prev Close 81.26 Low 79.41 High 81.71 Mkt Cap 47.07B
Vol 3.30M Avg Vol 4.62M EPS 1.81 P/E 44.78 Forward P/E 24.47
Beta 0.93 Short Ratio 2.27 Inst. Own 92.16% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 04-22 50-d Avg 81.88 200-d Avg 80.63 1yr Est 96.93
Earning
Date For Estimate Reported Surprise surprise %
2026-04-22 2026-03 0.72 N/A N/A N/A
2026-02-10 2025-12 0.62 0.58 -0.04 -6.45%
2025-10-30 2025-09 0.59 0.67 0.08 13.56%
2025-07-24 2025-06 0.62 0.67 0.05 8.06%
2025-04-23 2025-03 0.6 0.64 0.04 6.67%
2025-02-11 2024-12 0.55 0.59 0.04 7.27%
Upgrade / Downgrade
Date Firm Action From To
2026-02-11 Goldman Sachs Upgrade Buy Buy
2026-02-11 Piper Sandler Upgrade Overweight Overweight
2026-02-11 Truist Securities Upgrade Hold Hold
2026-02-11 Wells Fargo Upgrade Overweight Overweight
2026-02-11 BTIG Upgrade Buy Buy
2026-01-20 Stifel Upgrade Buy Buy
Profile
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Insider Holder
Date Name Relation Quantity Description
2026-04-01 BOBO DONALD E JR Officer 181.96K Conversion of Exercise of derivative security
2025-05-08 GALLAHUE KIERAN T. Director 79.66K Stock Award(Grant)
2024-05-06 LEMERCIER JEAN-LUC M Officer 184.79K Stock Award(Grant)
2025-05-08 LORANGER STEVEN R Director 80.05K Stock Award(Grant)
2024-05-01 MUSSALLEM MICHAEL A Director 4.04M Conversion of Exercise of derivative security
2024-09-02 SZYMAN CATHERINE M Officer 81.29K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 70.08M 5.68B 12.16%
2025-12-30 Blackrock Inc. 52.46M 4.25B 9.10%
2025-12-30 JPMORGAN CHASE & CO 26.02M 2.11B 4.51%
2025-12-30 State Street Corporation 25.99M 2.11B 4.51%
2025-12-30 Wellington Management Group, LLP 21.79M 1.77B 3.78%
2025-12-30 Bank Of New York Mellon Corporation 17.49M 1.42B 3.03%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 18.24M 1.48B 3.16%
2026-01-30 VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund 14.97M 1.21B 2.60%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 14.63M 1.19B 2.54%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 12.63M 1.02B 2.19%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 7.47M 605.24M 1.30%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 7.39M 598.56M 1.28%
Split
Split Date
3 : 1 2020-06-01
2 : 1 2015-12-14
2 : 1 2010-05-28
1 : 1 2010-05-27